ABBV
AbbVie Inc
264.40$
-0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.7% | -13.9% | +17.5% | 0.0% | +4.4% | -11.6% | +15.6% | +2.3% | +5.3% | -9.7% | +13.3% | – | |
| – | -12.0% | -28.2% | +2.6% | +0.2% | +4.4% | -9.0% | +8.6% | +22.0% | -14.2% | -7.3% | +1.7% | – | |
| – | +15.5% | -4.4% | +24.9% | -0.1% | +4.5% | -12.7% | +18.6% | -5.5% | +15.2% | -10.6% | +17.8% | – | |
| – | +28.2% | -12.2% | +0.5% | +9.3% | +218.0% | -69.5% | +3.1% | +8.8% | +11.2% | -4.1% | -5.2% | – | |
| – | -59.8% | +144.6% | +1.9% | +24.5% | -81.5% | +322.7% | -1.2% | +9.7% | +9.1% | -8.1% | +1.5% | – | |
| – | +4.7% | +0.3% | +15.6% | +2.5% | +90.1% | -54.0% | +10.3% | +38.6% | -27.0% | -3.3% | +3.6% | – | |
| – | +40.1% | -12.4% | +42.9% | -4.2% | -138.9% | – | +31.1% | -61.1% | +205.1% | -18.5% | +35.9% | – | |
| – | +1.6% | +17.0% | +10.0% | -0.8% | -2.5% | -0.3% | +5.7% | -0.1% | -3.4% | +0.4% | +4.0% | – | |
| – | -37.9% | +44.8% | +22.3% | -2.9% | -208.9% | – | -6.4% | -54.1% | +273.7% | -61.1% | +311.7% | – | |
| – | +125.6% | -1.3% | +101.8% | -32.7% | -531.9% | – | +64.8% | -14.2% | +62.2% | -59.9% | +93.6% | – | |
| – | -53.8% | +66.5% | +0.1% | +13.9% | -101.4% | – | -27.1% | -80.2% | +876.3% | -61.5% | +416.9% | – | |
| – | -18.8% | +16.5% | +11.5% | -2.4% | -89.0% | +722.4% | -1.3% | -19.1% | +52.7% | -31.2% | +134.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.